Skip to main content
Top
Published in: Hepatology International 2/2010

01-06-2010 | Letter to the Editor

Intravenous N-acetylcysteine in dengue-associated acute liver failure

Authors: Ravindu S. Kumarasena, S. Mananjala Senanayake, Krishan Sivaraman, Arjuna P. de Silva, Anuradha S. Dassanayake, Ranjan Premaratna, Bandula Wijesiriwardena, H. Janaka de Silva

Published in: Hepatology International | Issue 2/2010

Login to get access

Excerpt

We read with interest the article by Mumtaz et al. [1] on the role of oral N-acetylcysteine (NAC) in adults with non-acetaminophen-induced acute liver failure. We agree that their findings are of particular relevance to many developing countries, where liver transplantation is neither available nor affordable. There has been another recent study in which intravenous NAC has been shown to improve transplant-free survival in early-stage non-acetaminophen-induced acute liver failure in adults [2]. We report our initial experience in treating acute liver failure caused by dengue infection with NAC. Use of NAC in this situation has not been previously described. …
Literature
1.
go back to reference Mumtaz K, Azam Z, Hamid S, Abid S, Memon S, Shah HA, et al. Role of N-acetylcysteine in adults with non-acetaminophen induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009. Epub ahead of print Mumtaz K, Azam Z, Hamid S, Abid S, Memon S, Shah HA, et al. Role of N-acetylcysteine in adults with non-acetaminophen induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009. Epub ahead of print
2.
go back to reference Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. The Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage nonacetaminophen acute liver failure. Gastroenterology 2009;137:856–864CrossRefPubMed Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. The Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage nonacetaminophen acute liver failure. Gastroenterology 2009;137:856–864CrossRefPubMed
3.
go back to reference Seneviratne SL, Malavige GN, de Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg 2006;100:608–614CrossRefPubMed Seneviratne SL, Malavige GN, de Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg 2006;100:608–614CrossRefPubMed
4.
go back to reference Chongsrisawat V, Hutagalung Y, Poovorawan Y. Liver function test results and outcomes in children with acute liver failure due to dengue infection. Southeast Asian J Trop Med Public Health 2009;40:47–53PubMed Chongsrisawat V, Hutagalung Y, Poovorawan Y. Liver function test results and outcomes in children with acute liver failure due to dengue infection. Southeast Asian J Trop Med Public Health 2009;40:47–53PubMed
5.
go back to reference Penafiel A, Devanand A, Tan HK, Eng P. Use of molecular adsorbent recirculating system in acute liver failure attributable to dengue hemorrhagic fever. J Intensive Care Med 2006;21:369–371CrossRefPubMed Penafiel A, Devanand A, Tan HK, Eng P. Use of molecular adsorbent recirculating system in acute liver failure attributable to dengue hemorrhagic fever. J Intensive Care Med 2006;21:369–371CrossRefPubMed
6.
go back to reference World Health Organization. Guidelines for Treatment of Dengue Fever/Dengue Haemorrhagic Fever in Small Hospitals. New Delhi: WHO/SEARO; 1999 World Health Organization. Guidelines for Treatment of Dengue Fever/Dengue Haemorrhagic Fever in Small Hospitals. New Delhi: WHO/SEARO; 1999
7.
go back to reference Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179–1194CrossRefPubMed Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179–1194CrossRefPubMed
8.
go back to reference Ben-Ari Z, Vaknin H, Tur-Kaspa R. N-Acetylcysteine in acute hepatic failure (non-paracetamol-induced). Hepatogastroenterology 2000;47:786–789PubMed Ben-Ari Z, Vaknin H, Tur-Kaspa R. N-Acetylcysteine in acute hepatic failure (non-paracetamol-induced). Hepatogastroenterology 2000;47:786–789PubMed
9.
go back to reference Zwingmann C, Bilodeau M. Metabolic insights into the hepatoprotective effect of N-acetylcysteine in mouse liver. Hepatology 2006;43:454–463CrossRefPubMed Zwingmann C, Bilodeau M. Metabolic insights into the hepatoprotective effect of N-acetylcysteine in mouse liver. Hepatology 2006;43:454–463CrossRefPubMed
Metadata
Title
Intravenous N-acetylcysteine in dengue-associated acute liver failure
Authors
Ravindu S. Kumarasena
S. Mananjala Senanayake
Krishan Sivaraman
Arjuna P. de Silva
Anuradha S. Dassanayake
Ranjan Premaratna
Bandula Wijesiriwardena
H. Janaka de Silva
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 2/2010
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-010-9176-4

Other articles of this Issue 2/2010

Hepatology International 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.